return (
T

Tigermed AI

by Tigermed · Launched 2023

4.2/ 5.0

Tigermed AI is a powerful healthcare tool by Tigermed (China). Provides AI-powered healthcare capabilities for Clinical researchers, pharma companies.

HealthcareEnterprise
Visit Website
healthcareclinical-trialspharmadrug-discoveryresearch

Platforms

web

API

Available

Free Plan

No

Open Source

No

Mobile App

No

Views

N/A

Updated

July 30, 2026

Free Trial

No

Full Review

Tigermed AI: Complete Review

Tigermed AI, developed by Tigermed (China), is a leading healthcare tool launched in 2023. It has established itself as a go-to solution for Clinical researchers, pharma companies.

Key Features

Tigermed AI offers a range of powerful features. The platform combines ease of use with powerful AI. A robust API enables custom integrations.

Verdict

Tigermed AI earns a 4.2/5.0 rating. A solid choice for healthcare.

Features

AI clinical trial design
Data analysis
Regulatory compliance
Drug discovery assistance
Patient recruitment optimization
Safety monitoring
Real-world evidence
Biostatistics

Who It's For

Clinical researchers, pharma companies

Pros & Cons

Pros

  • Powerful capabilities
  • Strong features
  • Developer API
  • Regular updates

Cons

  • No free plan
  • Learning curve for advanced features

PricingEnterprise

Enterprise

Custom
  • Dedicated support
  • Custom integrations
  • SSO/SAML
Get Started

Use Cases

healthcare automation
Team collaboration
Content creation
Workflow optimization

Integrations

SlackZapierMakeREST APIWebhooks

Alternatives to Tigermed AI

Looking for something different? Here are the top alternatives worth considering.

Tags

healthcareclinical-trialspharmadrug-discoveryresearch

Frequently Asked Questions

Integrations

SlackZapierMakeREST APIWebhooks

Use Cases

healthcare automationTeam collaborationContent creationWorkflow optimization

Similar Tools

Stay ahead of the curve

Get the latest insights on AI, technology, and innovation delivered weekly.

Discussion (0)

Comments are moderated before publishing

);